WOBURN, Mass., April 02, 2020 (GLOBE NEWSWIRE) — Replimune Group Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies […]
Heidelberg, Germany, April 2, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]
WISeKey Selected by Global Manufacturer to Secure Drone FlightsThe rapid expansion of commercial drone market raises serious security concerns that […]